This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2013
Title: Christie M Del Castillo: Innovator in HIV Research
Introduction
Christie M Del Castillo is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for viral infections. With a total of 2 patents, her work focuses on advancing the understanding and treatment of HIV.
Latest Patents
One of her latest patents is titled "Chimeric protein for prevention and treatment of HIV infection." This invention relates to bispecific fusion proteins that are effective in viral neutralization. Specifically, these proteins possess two different binding domains: an inducing-binding domain and an induced-binding domain, which are functionally linked by a peptide linker. The patent details the proteins, nucleic acid molecules encoding them, and their production and use in preventing or treating viral infections. A prototypical bispecific fusion protein mentioned in the patent is sCD4-SCFv(17b), where a soluble CD4 fragment (containing domains D1 and D2) is fused to a single chain Fv portion of antibody 17b via a linker.
Career Highlights
Christie M Del Castillo works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to public health and innovation in medical research.
Collaborations
One of her notable collaborators is Edward A Berger, who has worked alongside her in advancing research in the field of HIV.
Conclusion
Christie M Del Castillo's innovative work in developing bispecific fusion proteins represents a significant advancement in the fight against HIV. Her contributions continue to pave the way for new therapeutic strategies in viral infection treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile